M. Buysschaert et al., Hyperhomocysteinemia in type 2 diabetes - Relationship to macroangiopathy,nephropathy, and insulin resistance, DIABET CARE, 23(12), 2000, pp. 1816-1822
OBJECTIVE - The aim of this study was to determine the distribution of plas
ma total homocysteine (tHcy) concentrations in type 2 diabetic patients and
to assess whether high tHcy values were related to chronic complications (
particularly macroangiopathy and nephropathy) and/or the degree of insulin
resistance.
RESEARCH DESIGN AND METHODS - Fasting tHcy levels were measured in 122 type
2 diabetic patients in whom the presence of chronic complications (e.g., m
acroangiopathy microalbuminuria, macroproteinuria, decreased creatinine cle
arance, hypertension, retinopathy; and neuropathy) was recorded alongside a
n assessment of insulin resistance by the homeostasis model assessment (HOM
A).
RESULTS - We found that 31% of the the cohort (group I) had raised tHcy (me
an +/- 1 SD) values (20.8 +/- 5.1 pmol/l), whereas 69% (group 2) had normal
values (10.2 +/- 2.0 mu mol/l). The prevalence of macroangiopathy was high
er in group 1 than in group 2 subjects (70 vs. 42%, P < 0.01); the prevalen
ce of coronary artery disease was particularly higher in group 1. (46 vs. 2
1%, P < 0.02). The prevalence of impaired renal function, evidenced by decr
eased creatinine clearance, was higher in group 1 (32 vs. 10%, P < 0.005).
Other clinical and biological characteristics of both groups were comparabl
e, although group I had lower levels of folic acid than group 2 (5.2 +/- 2.
9 vs. 7.0 +/- 3.4 ng/ml, P < 0.01). No differences were found for microalbu
minuria (33 vs. 31%), retinopathy (45 vs. 42%), or neuropathy (70 vs. 59%)
between groups I and 2, respectively The degree of insulin resistance was s
imilar in groups I and 2 (46 +/- 21 and 42 +/- 20% of HOMA-insulin sensitiv
ity) as was the assessment of beta -cell function (63 +/- 28 and 65 +/- 46%
, respectively). No differences in tHcy levels were found between subjects
receiving metformin and those not receiving metformin. In contrast, the pla
sma tHcy level was higher in diabetic patients treated with fibrates (P = 0
.0016).
CONCLUSIONS - Elevated plasma tHcy levels in type 2 diabetes is associated
with a higher prevalence of macroangiopathy and nephropathy when assessed f
rom creatinine clearance indexes and is not associated with different degre
es of insulin resistance.